Early research (Phase 1)Study completedNCT03777332
What this trial is testing
Study to Evaluate the Safety of Intravitreal APL-2 in Patients Diagnosed With Geographic Atrophy
Who this might be right for
Geographic Atrophy
Apellis Pharmaceuticals, Inc. 19